Policy & Medicine - Legal, Regulatory, and Compliance Issues

In 1979, the U.S. Department of Health and Human Services (HHS) began a process to improve the health of Americans through a…

Contained within the Affordable Care Act (ACA) was Section 1501, known as the Minimum Essential Coverage Provision (the…

One area that Senator Charles Grassley (R-IA) has focused on over the past several years has been investigating payments and…

As we noted last week, the New York Times decided to dig deep into ancient history to uncover what they thought was a clear story…

For the past 38 years, Tufts University School of Medicine and the Tufts Center for the Study of Drug Development (CSDD) have been…

Last month, the World Generic Medicines Congress Americas held its annual conference in Washington, DC. The conference was…

A recent opinion from the United States Court of Appeals for the First Circuit concluded that a Vermont law, which banned data…

The Tufts Center for the Study of Drug Development at Tufts University provides strategic information to help drug developers,…

In a speech last week at the FT Global Pharmaceutical and Biotechnology conference in London, AstraZeneca CEO David Brennan urged…

Criticism surrounding commercially supported continuing medical education (CME) has remained constant over the past several years,…